- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
-
- 长期趋势：
已有79家主力机构披露2024-06-30报告期持股数据，持仓量总计7.48亿股，占流通A股79.58%
- 波段诊断：
-
技术面诊股
诊断结果：2.9技术面打败了54%的股票
技术面评分前10的股票
近期的平均成本为11.61元。
平均成本
近期的平均成本为11.61元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"11.61","date":1732179010,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2024.11.22","stock":"-4.70","trade":"-3.81","ind":"-3.06"},{"date":"2024.11.21","stock":"-0.91","trade":"0.44","ind":"0.07"},{"date":"2024.11.20","stock":"1.35","trade":"1.98","ind":"0.66"},{"date":"2024.11.19","stock":"1.63","trade":"1.11","ind":"0.67"},{"date":"2024.11.18","stock":"-0.60","trade":"-1.71","ind":"-0.21"},{"date":"2024.11.15","stock":"-1.01","trade":"-2.21","ind":"-1.45"},{"date":"2024.11.14","stock":"-2.22","trade":"-2.33","ind":"-1.73"},{"date":"2024.11.13","stock":"0.00","trade":"-1.37","ind":"0.51"},{"date":"2024.11.12","stock":"0.00","trade":"1.95","ind":"-1.39"},{"date":"2024.11.11","stock":"0.17","trade":"0.61","ind":"0.51"},{"date":"2024.11.08","stock":"-0.08","trade":"-0.12","ind":"-0.53"},{"date":"2024.11.07","stock":"3.50","trade":"3.71","ind":"2.57"},{"date":"2024.11.06","stock":"-0.51","trade":"-0.03","ind":"-0.09"},{"date":"2024.11.05","stock":"1.38","trade":"1.93","ind":"2.32"},{"date":"2024.11.04","stock":"1.93","trade":"1.87","ind":"1.17"},{"date":"2024.11.01","stock":"0.35","trade":"-1.05","ind":"-0.24"},{"date":"2024.10.31","stock":"0.09","trade":"-0.21","ind":"0.42"},{"date":"2024.10.30","stock":"-1.82","trade":"-0.14","ind":"-0.61"},{"date":"2024.10.29","stock":"-4.86","trade":"-2.39","ind":"-1.08"},{"date":"2024.10.28","stock":"1.42","trade":"3.12","ind":"0.68"},{"date":"2024.10.25","stock":"1.27","trade":"0.66","ind":"0.59"}]
珍宝岛,上证指数,中药指数
压力支撑
该股压力位为11.58元，支撑位为11.25元。
[{"text":"\u538b\u529b\u4f4d","value":"11.58","date":1732204800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"11.25","date":1732204800,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.1资金面打败了80%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：11月22日 17:12
| 机构今日流向(万元) | -4755.42 | 机构5日流向(万元) | -6641.38 |
| 机构10日流向(万元) | -18968.55 | 机构20日流向(万元) | -25082.99 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量减少964.71万股，其中基金净减仓13家，主力净减仓6家，请投资者中长期谨慎为宜。
截止2024-06-30，共79家主力机构（基金70家，一般法人7家，券商2家），持仓量总计74766.75万股，占流通A股79.58%
其中，基金持仓与2023-12-31相比：
增仓：9家 ，增持 224.59万股
减仓：22家 ，减持 194.96万股
新出现在主力名单中：33家 ，持有1882.36万股
从主力名单中消失：39家 ，原持有1875.84万股
其中，基金持仓与2023-12-31相比：
增仓：9家 ，增持 224.59万股
减仓：22家 ，减持 194.96万股
新出现在主力名单中：33家 ，持有1882.36万股
从主力名单中消失：39家 ，原持有1875.84万股
消息面诊股
诊断结果：5.4消息面打败了73%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 磷酸奥司他韦胶囊、盐酸多奈哌齐片获批上市
2024-11-22 - 2023年度中国医药企业研发指数发布，洞悉中药产业
2024-11-22 - 珍宝岛：11月21日获融资买入680.71万元
2024-11-22 - 珍宝岛药业入选2023年度中国医药企业研发指数百强
2024-11-21 - 第89届全国药品交易会召开，这些国内药企的展品吸睛
2024-11-21 - 上半年心脑血管疾病中成药销售额超470亿元，7个品
2024-11-21 - 珍宝岛：11月20日获融资买入869.65万元，占
2024-11-21 - 珍宝岛药业“超级展位”亮相全国药品交易会，速效牛黄
2024-11-20 - 珍宝岛：11月19日获融资买入271.71万元，占
2024-11-20 - 珍宝岛：11月15日融券卖出金额6.46万元，占当
2024-11-18
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2024-11-16 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-10-17 |
| 一般消息 | 募资投向 | 2024-09-24 | |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2024-09-18 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-27 |
| 一般消息 | 高管变动 | 因个人原因 | 2024-07-19 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2024-07-12 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-07-12 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-06-30 |
| 利好 | 分红转增 | 10派2元(含税) | 2024-04-30 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-30 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2024-04-30 |
| 一般消息 | 募资投向 | 公司出售资产 | 2024-03-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-02-07 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2024-01-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2023-12-31 |
| 一般消息 | 高管变动 | 调整 | 2023-12-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2023-12-22 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 1条 | 3条 |
| 利空 | 3条 | 0条 | 3条 |
行业面诊股
诊断结果：2.5行业面打败了25%的股票
中药行业最新资金流向
近10日来该行业走势总体向下，接近大盘。
行业走势
近10日来该行业走势总体向下，接近大盘。
[{"date":"2024.11.22","price":"-3.06","value":"-3.81"},{"date":"2024.11.21","price":"0.07","value":"0.44"},{"date":"2024.11.20","price":"0.66","value":"1.98"},{"date":"2024.11.19","price":"0.67","value":"1.11"},{"date":"2024.11.18","price":"-0.21","value":"-1.71"},{"date":"2024.11.15","price":"-1.45","value":"-2.21"},{"date":"2024.11.14","price":"-1.73","value":"-2.33"},{"date":"2024.11.13","price":"0.51","value":"-1.37"},{"date":"2024.11.12","price":"-1.39","value":"1.95"},{"date":"2024.11.11","price":"0.51","value":"0.61"},{"date":"2024.11.08","price":"-0.53","value":"-0.12"},{"date":"2024.11.07","price":"2.57","value":"3.71"},{"date":"2024.11.06","price":"-0.09","value":"-0.03"},{"date":"2024.11.05","price":"2.32","value":"1.93"},{"date":"2024.11.04","price":"1.17","value":"1.87"},{"date":"2024.11.01","price":"-0.24","value":"-1.05"},{"date":"2024.10.31","price":"0.42","value":"-0.21"},{"date":"2024.10.30","price":"-0.61","value":"-0.14"},{"date":"2024.10.29","price":"-1.08","value":"-2.39"},{"date":"2024.10.28","price":"0.68","value":"3.12"},{"date":"2024.10.25","price":"0.59","value":"0.66"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 启迪药业 | 35.75% | 7.99% | 4.5分 |
| 2 | 嘉应制药 | 25.04% | 2.98% | 4.5分 |
| 3 | 香雪制药 | 21.67% | -6.43% | 3.6分 |
| 4 | 康美药业 | 15.50% | -2.12% | 4.0分 |
| 5 | 千金药业 | 14.90% | 20.04% | 5.4分 |
| 6 | 佛慈制药 | 13.49% | 2.94% | 4.6分 |
| 8 | 吉林敖东 | 9.29% | 0.87% | 4.3分 |
| 10 | *ST吉药 | 8.02% | -10.18% | 3.9分 |
| 12 | 信邦制药 | 7.67% | 5.87% | 5.1分 |
| 14 | ST九芝 | 6.67% | -8.02% | 4.3分 |
| 16 | ST百灵 | 5.50% | -6.28% | 4.0分 |
| 18 | 维康药业 | 4.64% | -4.14% | 3.9分 |
| 20 | 佐力药业 | 2.72% | 2.85% | 5.1分 |
| 22 | 益佰制药 | 2.41% | -1.29% | 4.0分 |
| 24 | 同仁堂 | 1.23% | -3.61% | 4.3分 |
| 26 | 太极集团 | 0.94% | -6.43% | 3.9分 |
| 28 | 汉森制药 | 0.49% | 0.32% | 4.8分 |
| 30 | 昆药集团 | -0.34% | -3.28% | 4.6分 |
| 32 | 康缘药业 | -0.76% | -4.16% | 4.2分 |
| 34 | 亚宝药业 | -0.98% | -0.98% | 4.8分 |
| 36 | 葵花药业 | -1.52% | -1.48% | 3.6分 |
| 38 | 白云山 | -1.65% | -2.87% | 4.8分 |
| 40 | 陇神戎发 | -1.84% | -1.52% | 4.0分 |
| 42 | 仁和药业 | -2.01% | -1.68% | 4.0分 |
| 44 | 红日药业 | -3.21% | -3.21% | 3.6分 |
| 46 | 华润三九 | -3.69% | -5.01% | 4.9分 |
| 48 | 桂林三金 | -3.96% | -1.82% | 4.8分 |
| 50 | 东阿阿胶 | -4.23% | -3.05% | 4.8分 |
| 52 | 长药控股 | -4.46% | -8.02% | 3.5分 |
| 54 | 莱茵生物 | -4.80% | -3.61% | 4.3分 |
| 56 | 华神科技 | -4.97% | 0.96% | 4.4分 |
| 58 | 珍宝岛 | -5.18% | -3.32% | 4.7分 |
| 60 | 贵州三力 | -5.53% | -2.92% | 5.0分 |
| 62 | 特一药业 | -6.33% | -1.13% | 3.7分 |
| 64 | 济川药业 | -7.11% | -5.56% | 4.5分 |
| 66 | 广誉远 | -8.56% | -4.06% | 4.0分 |
| 68 | 恩威医药 | -10.63% | -5.37% | 3.7分 |
| 70 | 方盛制药 | -13.97% | -5.77% | 4.7分 |
| 72 | - | -21.92% | -3.26% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 35/117 ， 34/117。
[{"date":"2024-09-30","value":"5.20","vol":"3.01"},{"date":"2024-06-30","value":"5.08","vol":"1.51"},{"date":"2024-03-31","value":"3.81","vol":"1.57"},{"date":"2023-12-31","value":"6.46","vol":"1.32"},{"date":"2023-09-30","value":"3.02","vol":"-36.03"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.20 | 5.08 | 3.81 | 6.46 | 3.02 |
| 行业(%) | 3.01 | 1.51 | 1.57 | 1.32 | -36.03 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"53.10","vol":"52.26"},{"date":"2024-06-30","value":"57.99","vol":"52.53"},{"date":"2024-03-31","value":"58.64","vol":"52.91"},{"date":"2023-12-31","value":"42.30","vol":"53.66"},{"date":"2023-09-30","value":"45.08","vol":"54.60"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
53.10 | 57.99 | 58.64 | 42.30 | 45.08 |
| 行业(%) | 52.26 | 52.53 | 52.91 | 53.66 | 54.60 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 25/117 ， 7/117。
[{"date":"2024-09-30","value":"-1.02","vol":"-4.89"},{"date":"2024-06-30","value":"7.10","vol":"-4.85"},{"date":"2024-03-31","value":"-11.59","vol":"-2.72"},{"date":"2023-12-31","value":"-25.53","vol":"3.91"},{"date":"2023-09-30","value":"-38.25","vol":"6.61"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-1.02 | 7.10 | -11.59 | -25.53 | -38.25 |
| 行业(%) | -4.89 | -4.85 | -2.72 | 3.91 | 6.61 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"83.22","vol":"-1.06"},{"date":"2024-06-30","value":"281.93","vol":"-20.25"},{"date":"2024-03-31","value":"24.00","vol":"-11.34"},{"date":"2023-12-31","value":"154.93","vol":"-18.78"},{"date":"2023-09-30","value":"41.43","vol":"9.62"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
83.22 | 281.93 | 24.00 | 154.93 | 41.43 |
| 行业(%) | -1.06 | -20.25 | -11.34 | -18.78 | 9.62 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 64/117 ， 58/117。
[{"date":"2024-09-30","value":"0.16","vol":"0.36"},{"date":"2024-06-30","value":"0.13","vol":"0.25"},{"date":"2024-03-31","value":"0.09","vol":"0.13"},{"date":"2023-12-31","value":"0.26","vol":"0.53"},{"date":"2023-09-30","value":"0.18","vol":"0.39"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.16 | 0.13 | 0.09 | 0.26 | 0.18 |
| 行业(次) | 0.36 | 0.25 | 0.13 | 0.53 | 0.39 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.95","vol":"1.77"},{"date":"2024-06-30","value":"0.76","vol":"1.21"},{"date":"2024-03-31","value":"0.66","vol":"0.65"},{"date":"2023-12-31","value":"2.10","vol":"2.83"},{"date":"2023-09-30","value":"1.12","vol":"2.04"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.95 | 0.76 | 0.66 | 2.10 | 1.12 |
| 行业(次) | 1.77 | 1.21 | 0.65 | 2.83 | 2.04 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"10.75","vol":"5.27"},{"date":"2024-06-30","value":"-19.88","vol":"9.55"},{"date":"2024-03-31","value":"-9.25","vol":"0.64"},{"date":"2023-12-31","value":"-15.26","vol":"19.92"},{"date":"2023-09-30","value":"-25.75","vol":"7.50"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 10.75 | -19.88 | -9.25 | -15.26 | -25.75 |
| 行业 | 5.27 | 9.55 | 0.64 | 19.92 | 7.50 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.24","vol":"1.34"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.47","vol":"1.43"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.24 | - | 0.47 | - |
| 行业 | 0.00 | 1.34 | 0.00 | 1.43 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 24/117 ， 43/117。
[{"date":"2024-09-30","value":"2.69","vol":"3.23"},{"date":"2024-06-30","value":"2.53","vol":"2.95"},{"date":"2024-03-31","value":"2.58","vol":"2.98"},{"date":"2023-12-31","value":"2.60","vol":"2.83"},{"date":"2023-09-30","value":"2.31","vol":"2.95"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.69 | 2.53 | 2.58 | 2.60 | 2.31 |
| 行业 | 3.23 | 2.95 | 2.98 | 2.83 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"2.07","vol":"2.43"},{"date":"2024-06-30","value":"2.03","vol":"2.24"},{"date":"2024-03-31","value":"2.21","vol":"2.29"},{"date":"2023-12-31","value":"2.15","vol":"2.15"},{"date":"2023-09-30","value":"1.74","vol":"2.23"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.07 | 2.03 | 2.21 | 2.15 | 1.74 |
| 行业 | 2.43 | 2.24 | 2.29 | 2.15 | 2.23 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 22/117 ， 27/117。
[{"date":"2024-09-30","value":"35.06","vol":"34.45"},{"date":"2024-06-30","value":"35.29","vol":"35.22"},{"date":"2024-03-31","value":"35.30","vol":"34.41"},{"date":"2023-12-31","value":"35.50","vol":"34.63"},{"date":"2023-09-30","value":"36.28","vol":"34.12"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
35.06 | 35.29 | 35.30 | 35.50 | 36.28 |
| 行业(%) | 34.45 | 35.22 | 34.41 | 34.63 | 34.12 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.57","vol":"3.07"},{"date":"2024-06-30","value":"0.58","vol":"1.58"},{"date":"2024-03-31","value":"0.58","vol":"0.95"},{"date":"2023-12-31","value":"0.59","vol":"0.86"},{"date":"2023-09-30","value":"0.57","vol":"0.59"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.57 | 0.58 | 0.58 | 0.59 | 0.57 |
| 行业(%) | 3.07 | 1.58 | 0.95 | 0.86 | 0.59 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"4.36","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"3.32","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.85","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.73","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.97","blueLineValue":"0.63","type":"YC"}]